ArticleFrontiers in pharmacology2025

Oral administration of Ketamir-2, a novel ketamine analog, attenuates neuropathic pain in rodent models via selective NMDA antagonism.

Itzchak Angel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.